Search

Author/Creator Choon Tan, Aik

1. A Phase I Dose‐Escalation Study of Linsitinib (OSI‐906), a Small‐Molecule Dual Insulin‐Like Growth Factor‐1 Receptor/Insulin Receptor Kinase Inhibitor, in Combination with Irinotecan in Patients with Advanced Cancer. (23rd August 2018)

Authors:
Davis, S. Lindsey; Eckhardt, S. Gail; Diamond, Jennifer R.; Messersmith, Wells A.; Dasari, Arvind; Weekes, Colin D.; Lieu, Christopher H.; Kane, Madeline; Choon Tan, Aik; Pitts, Todd M.; Leong, Stephen
Journal:
Oncologist
Issue:
Volume 23:Number 12(2018)
Page Start:
1409
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation. (5th September 2017)

Authors:
Cavalli, Giulio; Koenders, Marije; Kalabokis, Vassili; Kim, Jihye; Choon Tan, Aik; Garlanda, Cecilia; Mantovani, Alberto; Dagna, Lorenzo; Joosten, Leo A. B.; Dinarello, Charles A.
Journal:
Rheumatology
Issue:
Volume 56:Number 12(2017)
Page Start:
2256
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search